Latest Safety News

Avecho Biotechnology is on the cusp of completing patient dosing in its pivotal Phase III CBD insomnia trial, backed by a recent $2.5 million capital raise and patent allowances in the US and Europe.

InhaleRx Limited has progressed its clinical trials for three drug candidates targeting cancer pain, panic disorder, and treatment-resistant depression, while securing additional funding and preparing for a company rebrand.

Avenira Limited has made significant strides in developing its Wonarah Phosphate Project, bolstered by strategic operational appointments and advancing infrastructure plans. Meanwhile, exploration at the Jundee South Gold Project is set to commence in 2026 amid ongoing regulatory challenges.

Immutep Limited has entered a strategic collaboration with Dr. Reddy’s, receiving a A$30 million upfront payment and potential milestones up to A$528 million, while reporting promising clinical progress across multiple cancer immunotherapy trials.

Syntara Limited has made significant strides in its clinical pipeline, launching new trials and receiving key regulatory designations, positioning 2026 as a pivotal year for the company.

Aeris Resources delivered solid Q2 FY26 results with copper equivalent production of 10.1kt at competitive costs, strengthened its balance sheet by repaying debt, and reported promising exploration outcomes that could underpin future growth.

Blaze Minerals has confirmed a new critical mineral discovery of gallium and rubidium at its Ntungamo Project in Uganda, while withdrawing from its Congo base metals venture due to security concerns.

Terramin Australia has made significant progress on its Tala Hamza zinc project and Kapunda copper recovery tests while navigating legal challenges at Bird in Hand. The company also completed a $38.3 million rights issue to strengthen its balance sheet and fund development.

Ark Mines has made significant strides in advancing its Sandy Mitchell Rare Earths Project, initiating a full-scale processing trial and securing critical environmental approvals, setting the stage for production by late 2027.

Imagion Biosystems has completed manufacturing its MagSense® HER2 imaging agent and is preparing for a key FDA submission, while appointing a new president to lead its US operations.

Liontown Limited has successfully transitioned to fully underground lithium mining at Kathleen Valley, boosting production and revenue while cutting costs. The company also secured a significant new offtake agreement and validated strong market demand through its inaugural spodumene auction.

Strike Energy reports steady progress on its South Erregulla gas power project, while optimising Walyering production and maintaining strong liquidity. The company navigates market conditions with a strategic reduction in output and plans for upcoming drilling activities.